857119P
06:0 Lyso PA
Manufacturer: Sigma Aldrich
CAS Number: 384835-45-4
Synonym(S): 1-hexanoyl-sn-glycero-3-phosphate (ammonium salt); PA(6:0/0:0)
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 25 MG | 857119P-25-MG | In Stock | ₹ 53,876.03 |
857119P - 25 MG
In Stock
Quantity
1
Base Price: ₹ 53,876.03
GST (18%): ₹ 9,697.685
Total Price: ₹ 63,573.715
description
1-hexanoyl-2-hydroxy-sn-glycero-3-phosphate (ammonium salt)
Assay
>99% (LPA; may contain up to 10% of the 2-LPA isomer, TLC)
form
powder
packaging
pkg of 1 × 25 mg (857119P-25mg)
manufacturer/tradename
Avanti Polar Lipids
lipid type
cardiolipinsphospholipids
shipped in
dry ice
storage temp.
−20°C
SMILES string
O[C@](COP([O-])(O)=O)([H])COC(CCCCC)=O.[NH4+]
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | 384835-45-4 | 1-hexanoyl-2-hydroxy-sn-glycero-3-phosphate (ammonium salt) | A2B Chem | ₹ 1,49,730.00 |
Related Products
Description
- General description: Lysophosphatidic acid (LPA) belongs to a class of phospholipids, that has a glycerol backbone attached by a phosphate group, an aliphatic chain and a hydroxyl group. It has a phosphate group attached to sn-3 position, an aliphatic chain attached to sn-1 or sn-2 position and the hydroxyl group attached to the remaining sn-1 or sn-2 position.[1] 06:0 Lyso PA/HHGP, belongs to the LPA (lysophosphatidic acid) family.[2] It is a negatively charged single chain lipid.[3]
- Application: 06:0 Lyso PA (LPA) has been used in the structure-activity relationship (SAR) analysis with G-protein receptor GPR92.[6] It has also been used in lipid assay in the treatment of serum-starved primary mouse embryonic fibroblast cells.[7]
- Biochem/physiol Actions: Lysophosphatidic acid (LPA) is the precursor for the synthesis of phospholipids in eukaryotes and prokaryotes. It acts as an intercellular signaling molecule.[4] Activated platelets produce LPA.[5] It plays a major role in tissue healing and wound regeneration. LPA binds to G-protein coupled receptors. It possesses mitogenic properties.[4] LPA inhibits differentiation of neuroblastoma and myoblast, aids in neurotransmitter release and smooth muscle contraction.[5] It is a potential biomarker for ovarian and gynecological cancers.[8] It is implicated in the initiation of neuropathic pain.[9]
- Packaging: 5 mL Amber Glass Screw Cap Vial (857119P-25mg)
Compare Similar Items
Show Difference
description: 1-hexanoyl-2-hydroxy-sn-glycero-3-phosphate (ammonium salt)
Assay: >99% (LPA; may contain up to 10% of the 2-LPA isomer, TLC)
form: powder
packaging: pkg of 1 × 25 mg (857119P-25mg)
manufacturer/tradename: Avanti Polar Lipids
lipid type: cardiolipinsphospholipids
shipped in: dry ice
storage temp.: −20°C
SMILES string: O[C@](COP([O-])(O)=O)([H])COC(CCCCC)=O.[NH4+]
description:
1-hexanoyl-2-hydroxy-sn-glycero-3-phosphate (ammonium salt)
Assay:
>99% (LPA; may contain up to 10% of the 2-LPA isomer, TLC)
form:
powder
packaging:
pkg of 1 × 25 mg (857119P-25mg)
manufacturer/tradename:
Avanti Polar Lipids
lipid type:
cardiolipinsphospholipids
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
O[C@](COP([O-])(O)=O)([H])COC(CCCCC)=O.[NH4+]
description: __
Assay: >99% (LPA; may contain up to 10% of the 2-LPA isomer, TLC)
form: powder
packaging: pkg of 1 × 25 mg (857127P-25mg)
manufacturer/tradename: Avanti Polar Lipids 857127P
lipid type: phospholipidscardiolipins
shipped in: dry ice
storage temp.: −20°C
SMILES string: __
description:
__
Assay:
>99% (LPA; may contain up to 10% of the 2-LPA isomer, TLC)
form:
powder
packaging:
pkg of 1 × 25 mg (857127P-25mg)
manufacturer/tradename:
Avanti Polar Lipids 857127P
lipid type:
phospholipidscardiolipins
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
__
description: 1-stearoyl-2-hydroxy-sn-glycero-3-phosphate (sodium salt)
Assay: >99% (LPA; may contain up to 10% of the 2-LPA isomer, TLC)
form: powder
packaging: pkg of 1 × 25 mg (857128P-25mg)
manufacturer/tradename: Avanti Polar Lipids
lipid type: cardiolipinsphospholipids
shipped in: dry ice
storage temp.: −20°C
SMILES string: O[C@](COP([O-])(O)=O)([H])COC(CCCCCCCCCCCCCCCCC)=O.[Na+]
description:
1-stearoyl-2-hydroxy-sn-glycero-3-phosphate (sodium salt)
Assay:
>99% (LPA; may contain up to 10% of the 2-LPA isomer, TLC)
form:
powder
packaging:
pkg of 1 × 25 mg (857128P-25mg)
manufacturer/tradename:
Avanti Polar Lipids
lipid type:
cardiolipinsphospholipids
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
O[C@](COP([O-])(O)=O)([H])COC(CCCCCCCCCCCCCCCCC)=O.[Na+]
description: __
Assay: >99% (LPA; may contain up to 10% of the 2-LPA isomer, TLC)
form: liquid
packaging: pkg of 1 × 2.5 mL (857130C-25mg)pkg of 2 × 4 mL (857130C-200mg)
manufacturer/tradename: Avanti Polar Lipids 857130C
lipid type: cardiolipinsphospholipids
shipped in: dry ice
storage temp.: −20°C
SMILES string: __
description:
__
Assay:
>99% (LPA; may contain up to 10% of the 2-LPA isomer, TLC)
form:
liquid
packaging:
pkg of 1 × 2.5 mL (857130C-25mg)pkg of 2 × 4 mL (857130C-200mg)
manufacturer/tradename:
Avanti Polar Lipids 857130C
lipid type:
cardiolipinsphospholipids
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
__